News
Brief news reports on Tuberculosis
By
Treatment Action Group
Published: March 15, 2013, 11:13 p.m.·
Tags:
None
Re: Urgent recommendations to address and resolve ongoing shortages of tuberculosis drugs in the United States
Read More →
By
Stop TB Partnership
Published: March 15, 2013, 10:53 p.m.·
Tags:
None
The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.
Read More →
By
Médecins Sans Frontières
Published: March 15, 2013, 10:40 p.m.·
Tags:
None
Tokyo, 15 March 2013 – Following Prime Minister Abe’s announcement today of Japan’s intention to join the Trans-Pacific Partnership (TPP) Agreement negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) called on Japan and the rest of TPP negotiating countries to reject rules that threaten to dismantle internationally-agreed public health safeguards and restrict access to medicines in developing countries.
Read More →
By
TB/HIV Working Group
Published: March 15, 2013, 10:21 p.m.·
Tags:
None
The World Health Organization and the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) convened their 7th CROI-affiliated HIV/TB research meeting on behalf of the TB/HIV Working Group of the Stop TB Partnership in Atlanta, Georgia USA on 3 March, 2013. The meeting discussed critical knowledge and research gaps on TB prevention among children and adults and drug interactions between new TB drugs and ART. Attended by some 100 participants, the meeting was convened by Dr Haileyesus Getahun of WHO and co-chaired by Dr Diane Havlir of UCSF and Chair of the Global TB/HIV Working Group and Dr Richard Chaisson, of Johns Hopkins and Director of CREATE.
Read More →
By
TB CAB,
Treatment Action Group
Published: March 15, 2013, 6:09 p.m.·
Tags:
Advocacy,
Access
Determining a fair and affordable price of bedaquiline is essential for timely approval and appropriate domestic and global access to the best possible therapeutic options for people with DR-TB.
Read More →
By
University of Liverpool
Published: March 15, 2013, 3:04 p.m.·
Tags:
None
The PreDiCT-TB consortium and the Critical Path to TB Regimens have announced the signing of a memorandum of understanding outlining plans to co-ordinate their activities in the area of TB drug development methodology.
Read More →
By
Jake Miller
Published: March 15, 2013, 2:49 p.m.·
Tags:
None
Findings provide guidance for global policy and clinical approach in treatable disease that kills millions worldwide.
Read More →
By
Médecins Sans Frontières
Published: March 15, 2013, 1:50 p.m.·
Tags:
None
Few children at the paediatric tuberculosis hospital in Dushanbe look as active and healthy as Shirinmo. The little girl is bright and busy as she crawls across the waiting room floor. But get closer and you can hear that her breath comes in gasps and has a rattling sound. The devastating diagnosis: the nine-month-old is suffering from multidrug-resistant tuberculosis (MDR-TB), a disease that spreads easily and, if left untreated, kills.
Read More →
By
University of Cape Town
Published: March 15, 2013, 1:40 p.m.·
Tags:
None
H3-D director Prof Kelly Chibale, (front centre) with his research team. H3-D's partnership with Novartis will augment support already provided by the South African government's Department of Science & Technology and Technology Innovation Agency to build drug discovery and development capabilities on the African continent.
Read More →
By
Medecins Sans Frontieres
Published: March 13, 2013, 9:28 p.m.·
Tags:
None
DNP+, MSF urge India to reject EU demands before April deadline, protest at European Commission in Delhi
Read More →
Page 747 of 878 · Total posts: 10
←First
746
747
748
Last→